| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 42 | 2022 | 450 | 8.770 |
Why?
|
| Heart Defects, Congenital | 50 | 2022 | 596 | 8.330 |
Why?
|
| Infant, Newborn | 61 | 2023 | 2455 | 3.130 |
Why?
|
| Critical Care | 16 | 2023 | 263 | 2.790 |
Why?
|
| Extracorporeal Membrane Oxygenation | 9 | 2022 | 123 | 2.500 |
Why?
|
| Infant, Premature, Diseases | 4 | 2022 | 85 | 2.280 |
Why?
|
| Infant | 57 | 2023 | 2891 | 2.260 |
Why?
|
| Postoperative Complications | 24 | 2022 | 1615 | 2.130 |
Why?
|
| Child | 61 | 2023 | 6405 | 2.060 |
Why?
|
| Heart Diseases | 10 | 2019 | 276 | 1.960 |
Why?
|
| Child, Preschool | 45 | 2023 | 3187 | 1.890 |
Why?
|
| Intensive Care Units, Pediatric | 17 | 2021 | 101 | 1.820 |
Why?
|
| Fontan Procedure | 10 | 2018 | 129 | 1.730 |
Why?
|
| Heart Arrest | 4 | 2021 | 113 | 1.720 |
Why?
|
| Heart Septal Defects, Ventricular | 4 | 2016 | 59 | 1.610 |
Why?
|
| Heart Transplantation | 9 | 2023 | 328 | 1.600 |
Why?
|
| Premature Birth | 2 | 2022 | 150 | 1.410 |
Why?
|
| Heart Failure | 9 | 2016 | 1180 | 1.350 |
Why?
|
| Humans | 120 | 2023 | 68618 | 1.300 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2018 | 250 | 1.290 |
Why?
|
| Retrospective Studies | 47 | 2022 | 7277 | 1.290 |
Why?
|
| Hospital Mortality | 12 | 2022 | 384 | 1.170 |
Why?
|
| Postoperative Care | 7 | 2019 | 163 | 1.160 |
Why?
|
| Coronary Care Units | 4 | 2017 | 12 | 1.090 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2022 | 113 | 1.080 |
Why?
|
| Aorta, Thoracic | 4 | 2017 | 211 | 1.020 |
Why?
|
| Catheterization, Central Venous | 5 | 2013 | 89 | 0.950 |
Why?
|
| Treatment Outcome | 33 | 2023 | 7029 | 0.930 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2021 | 138 | 0.920 |
Why?
|
| Airway Extubation | 4 | 2020 | 17 | 0.920 |
Why?
|
| Female | 65 | 2022 | 38074 | 0.920 |
Why?
|
| Cardiac Output, Low | 4 | 2022 | 52 | 0.900 |
Why?
|
| Myocarditis | 2 | 2016 | 49 | 0.870 |
Why?
|
| Natriuretic Peptide, Brain | 5 | 2017 | 101 | 0.870 |
Why?
|
| Risk Factors | 25 | 2022 | 5731 | 0.860 |
Why?
|
| Pediatrics | 7 | 2018 | 341 | 0.850 |
Why?
|
| Quality of Life | 5 | 2020 | 1515 | 0.850 |
Why?
|
| Pulmonary Valve | 1 | 2023 | 40 | 0.850 |
Why?
|
| Perioperative Care | 4 | 2017 | 100 | 0.850 |
Why?
|
| Reoperation | 6 | 2018 | 467 | 0.840 |
Why?
|
| Pulmonary Artery | 6 | 2020 | 323 | 0.830 |
Why?
|
| Hyperglycemia | 4 | 2015 | 158 | 0.820 |
Why?
|
| Communication Aids for Disabled | 1 | 2022 | 3 | 0.810 |
Why?
|
| Heart Ventricles | 7 | 2017 | 738 | 0.810 |
Why?
|
| Communication Disorders | 1 | 2022 | 12 | 0.810 |
Why?
|
| Voice | 1 | 2022 | 16 | 0.800 |
Why?
|
| Gestational Age | 4 | 2022 | 389 | 0.790 |
Why?
|
| Hospital Rapid Response Team | 1 | 2021 | 9 | 0.780 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2022 | 37 | 0.780 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2023 | 164 | 0.760 |
Why?
|
| Male | 60 | 2021 | 37321 | 0.750 |
Why?
|
| Adolescent | 27 | 2023 | 8912 | 0.740 |
Why?
|
| Survival Rate | 9 | 2018 | 1056 | 0.730 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2022 | 99 | 0.730 |
Why?
|
| Palliative Care | 4 | 2018 | 271 | 0.730 |
Why?
|
| Vascular Resistance | 3 | 2019 | 179 | 0.700 |
Why?
|
| Vascular Surgical Procedures | 4 | 2018 | 168 | 0.690 |
Why?
|
| Catheter-Related Infections | 4 | 2013 | 43 | 0.680 |
Why?
|
| Heart Septal Defects | 2 | 2016 | 27 | 0.680 |
Why?
|
| Length of Stay | 9 | 2023 | 780 | 0.660 |
Why?
|
| Prenatal Diagnosis | 2 | 2019 | 73 | 0.660 |
Why?
|
| Registries | 7 | 2019 | 733 | 0.660 |
Why?
|
| Fluid Therapy | 2 | 2016 | 59 | 0.650 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2016 | 72 | 0.630 |
Why?
|
| Cardiology | 5 | 2021 | 140 | 0.610 |
Why?
|
| Proxy | 2 | 2015 | 8 | 0.610 |
Why?
|
| Heart | 1 | 2022 | 850 | 0.600 |
Why?
|
| Intensive Care Units | 4 | 2023 | 344 | 0.600 |
Why?
|
| Anemia, Hemolytic | 1 | 2017 | 37 | 0.590 |
Why?
|
| Models, Organizational | 1 | 2017 | 97 | 0.580 |
Why?
|
| Vasodilator Agents | 4 | 2019 | 138 | 0.570 |
Why?
|
| Follow-Up Studies | 14 | 2020 | 3259 | 0.570 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2016 | 9 | 0.560 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 236 | 0.550 |
Why?
|
| Respiratory Insufficiency | 2 | 2015 | 76 | 0.550 |
Why?
|
| Edema, Cardiac | 1 | 2016 | 1 | 0.540 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2016 | 37 | 0.540 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2016 | 38 | 0.540 |
Why?
|
| Time Factors | 18 | 2022 | 4655 | 0.520 |
Why?
|
| Truncus Arteriosus, Persistent | 3 | 2020 | 17 | 0.510 |
Why?
|
| Positive-Pressure Respiration | 1 | 2015 | 27 | 0.510 |
Why?
|
| Cross Infection | 4 | 2011 | 195 | 0.510 |
Why?
|
| Blood Glucose | 5 | 2015 | 631 | 0.510 |
Why?
|
| Respiration, Artificial | 5 | 2019 | 190 | 0.490 |
Why?
|
| Milrinone | 1 | 2014 | 12 | 0.480 |
Why?
|
| Pregnancy | 5 | 2022 | 2334 | 0.470 |
Why?
|
| Down Syndrome | 1 | 2015 | 120 | 0.460 |
Why?
|
| Diverticulum | 1 | 2014 | 29 | 0.450 |
Why?
|
| Coronary Vessel Anomalies | 3 | 2020 | 45 | 0.440 |
Why?
|
| Wounds, Penetrating | 1 | 2013 | 45 | 0.430 |
Why?
|
| Pneumothorax | 1 | 2013 | 42 | 0.430 |
Why?
|
| Aortic Diseases | 1 | 2014 | 113 | 0.430 |
Why?
|
| United States | 17 | 2021 | 7367 | 0.420 |
Why?
|
| Cardiac Output | 4 | 2016 | 133 | 0.420 |
Why?
|
| Bacteremia | 3 | 2010 | 155 | 0.420 |
Why?
|
| Arteries | 1 | 2013 | 108 | 0.410 |
Why?
|
| Infant, Low Birth Weight | 2 | 2022 | 84 | 0.390 |
Why?
|
| Thrombosis | 1 | 2013 | 218 | 0.390 |
Why?
|
| Atrial Natriuretic Factor | 3 | 2006 | 54 | 0.380 |
Why?
|
| Diuretics | 2 | 2016 | 97 | 0.380 |
Why?
|
| Age Factors | 6 | 2019 | 1864 | 0.370 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 481 | 0.370 |
Why?
|
| Cohort Studies | 8 | 2022 | 2358 | 0.370 |
Why?
|
| Recovery of Function | 1 | 2014 | 506 | 0.370 |
Why?
|
| Birth Weight | 2 | 2021 | 186 | 0.360 |
Why?
|
| Heart Valves | 2 | 2023 | 171 | 0.350 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2019 | 504 | 0.350 |
Why?
|
| Survival Analysis | 4 | 2017 | 714 | 0.350 |
Why?
|
| Cardiac Catheterization | 4 | 2019 | 419 | 0.350 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 1046 | 0.350 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2015 | 36 | 0.340 |
Why?
|
| Heart-Assist Devices | 3 | 2017 | 221 | 0.340 |
Why?
|
| Lyme Disease | 1 | 2009 | 17 | 0.330 |
Why?
|
| Infant, Premature | 4 | 2014 | 284 | 0.330 |
Why?
|
| Quality Improvement | 6 | 2021 | 413 | 0.330 |
Why?
|
| Risk Assessment | 6 | 2019 | 2007 | 0.330 |
Why?
|
| Surgical Wound Infection | 1 | 2010 | 168 | 0.320 |
Why?
|
| Logistic Models | 6 | 2019 | 1420 | 0.310 |
Why?
|
| Surveys and Questionnaires | 6 | 2021 | 2800 | 0.310 |
Why?
|
| Natriuretic Agents | 2 | 2006 | 9 | 0.310 |
Why?
|
| Parents | 3 | 2020 | 312 | 0.310 |
Why?
|
| Physicians | 2 | 2021 | 324 | 0.310 |
Why?
|
| Cooperative Behavior | 3 | 2021 | 235 | 0.300 |
Why?
|
| Cardiovascular Surgical Procedures | 3 | 2017 | 36 | 0.300 |
Why?
|
| Ultrasonography, Interventional | 2 | 2013 | 119 | 0.300 |
Why?
|
| Thoracic Surgery | 2 | 2020 | 72 | 0.300 |
Why?
|
| Communication | 2 | 2022 | 329 | 0.290 |
Why?
|
| Infection Control | 1 | 2008 | 101 | 0.290 |
Why?
|
| Critical Illness | 5 | 2016 | 191 | 0.270 |
Why?
|
| Morbidity | 4 | 2019 | 130 | 0.270 |
Why?
|
| Intubation, Intratracheal | 2 | 2017 | 99 | 0.270 |
Why?
|
| Fenoldopam | 1 | 2006 | 1 | 0.270 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 232 | 0.260 |
Why?
|
| Boston | 5 | 2012 | 35 | 0.260 |
Why?
|
| Edema | 1 | 2006 | 66 | 0.260 |
Why?
|
| Prospective Studies | 5 | 2023 | 3705 | 0.250 |
Why?
|
| Cross-Sectional Studies | 6 | 2022 | 2279 | 0.250 |
Why?
|
| Monitoring, Physiologic | 2 | 2021 | 219 | 0.240 |
Why?
|
| Healthcare Disparities | 2 | 2019 | 378 | 0.240 |
Why?
|
| Hospitalization | 2 | 2022 | 978 | 0.240 |
Why?
|
| Echocardiography | 2 | 2016 | 515 | 0.220 |
Why?
|
| Blood Component Transfusion | 1 | 2003 | 11 | 0.220 |
Why?
|
| Rhabdomyoma | 1 | 2003 | 7 | 0.220 |
Why?
|
| Societies, Medical | 2 | 2016 | 403 | 0.220 |
Why?
|
| Aprotinin | 1 | 2003 | 55 | 0.210 |
Why?
|
| Heart Neoplasms | 1 | 2003 | 33 | 0.210 |
Why?
|
| Hemostatics | 1 | 2003 | 47 | 0.210 |
Why?
|
| Transplantation, Homologous | 1 | 2023 | 242 | 0.210 |
Why?
|
| Bronchitis | 1 | 2002 | 8 | 0.210 |
Why?
|
| Treatment Failure | 3 | 2019 | 216 | 0.200 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2022 | 5 | 0.200 |
Why?
|
| Medical Informatics | 1 | 2023 | 71 | 0.200 |
Why?
|
| Pseudohypoaldosteronism | 1 | 2021 | 4 | 0.200 |
Why?
|
| Hyponatremia | 1 | 2021 | 20 | 0.190 |
Why?
|
| Adult | 13 | 2023 | 21403 | 0.190 |
Why?
|
| Neonatology | 1 | 2021 | 29 | 0.190 |
Why?
|
| Aortic Valve | 1 | 2023 | 249 | 0.190 |
Why?
|
| Telemedicine | 2 | 2020 | 700 | 0.190 |
Why?
|
| Hypoxia | 1 | 2002 | 169 | 0.190 |
Why?
|
| Coronary Disease | 1 | 2003 | 358 | 0.190 |
Why?
|
| Bland White Garland Syndrome | 1 | 2020 | 1 | 0.190 |
Why?
|
| Electrocardiography | 2 | 2016 | 601 | 0.190 |
Why?
|
| Tracheostomy | 1 | 2020 | 31 | 0.180 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 191 | 0.180 |
Why?
|
| Hypoglycemic Agents | 3 | 2015 | 362 | 0.180 |
Why?
|
| Cardiomyopathies | 2 | 2013 | 167 | 0.170 |
Why?
|
| Pulmonary Circulation | 1 | 2019 | 79 | 0.170 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2019 | 31 | 0.170 |
Why?
|
| Truncus Arteriosus | 1 | 2019 | 5 | 0.170 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2002 | 296 | 0.170 |
Why?
|
| Insulin | 2 | 2015 | 619 | 0.170 |
Why?
|
| Postoperative Period | 4 | 2018 | 238 | 0.160 |
Why?
|
| Fellowships and Scholarships | 2 | 2021 | 127 | 0.160 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 649 | 0.160 |
Why?
|
| Interinstitutional Relations | 1 | 2018 | 49 | 0.160 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 114 | 0.160 |
Why?
|
| Health Care Surveys | 2 | 2018 | 239 | 0.160 |
Why?
|
| Publications | 1 | 2018 | 17 | 0.160 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2018 | 3 | 0.160 |
Why?
|
| Global Health | 1 | 2018 | 136 | 0.150 |
Why?
|
| Noninvasive Ventilation | 1 | 2017 | 5 | 0.150 |
Why?
|
| Clinical Competence | 3 | 2018 | 657 | 0.150 |
Why?
|
| Home Care Services | 1 | 2018 | 84 | 0.150 |
Why?
|
| Incidence | 2 | 2021 | 1603 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 296 | 0.150 |
Why?
|
| Nitric Oxide | 1 | 2019 | 382 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 498 | 0.150 |
Why?
|
| Diagnostic Errors | 1 | 2018 | 100 | 0.150 |
Why?
|
| Coronary Angiography | 1 | 2003 | 866 | 0.150 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 188 | 0.140 |
Why?
|
| Data Collection | 1 | 2018 | 420 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 83 | 0.140 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 1465 | 0.140 |
Why?
|
| Multidetector Computed Tomography | 1 | 2017 | 60 | 0.140 |
Why?
|
| Stress, Psychological | 2 | 2020 | 824 | 0.140 |
Why?
|
| Bioprosthesis | 1 | 2017 | 101 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2016 | 24 | 0.140 |
Why?
|
| Illinois | 1 | 2016 | 5 | 0.140 |
Why?
|
| Aorta | 1 | 2018 | 316 | 0.140 |
Why?
|
| Heart Rate | 2 | 2016 | 568 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 177 | 0.140 |
Why?
|
| Young Adult | 8 | 2022 | 5717 | 0.140 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2016 | 12 | 0.140 |
Why?
|
| Renal Replacement Therapy | 1 | 2016 | 40 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 42 | 0.140 |
Why?
|
| Subclavian Artery | 1 | 2016 | 30 | 0.130 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2016 | 21 | 0.130 |
Why?
|
| Quality of Health Care | 1 | 2019 | 322 | 0.130 |
Why?
|
| Computed Tomography Angiography | 2 | 2017 | 424 | 0.130 |
Why?
|
| Neurologic Examination | 1 | 2016 | 107 | 0.130 |
Why?
|
| Hyperlactatemia | 1 | 2015 | 1 | 0.130 |
Why?
|
| Tachycardia | 1 | 2015 | 53 | 0.130 |
Why?
|
| Lactates | 1 | 2015 | 29 | 0.130 |
Why?
|
| Double-Blind Method | 2 | 2022 | 1738 | 0.130 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2015 | 13 | 0.130 |
Why?
|
| Databases, Factual | 2 | 2019 | 622 | 0.130 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 35 | 0.130 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2015 | 8 | 0.130 |
Why?
|
| Propionic Acidemia | 1 | 2015 | 2 | 0.130 |
Why?
|
| Metformin | 1 | 2015 | 63 | 0.130 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2015 | 16 | 0.130 |
Why?
|
| Myocardial Contraction | 1 | 2016 | 383 | 0.130 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2015 | 20 | 0.120 |
Why?
|
| Ventilator Weaning | 2 | 2019 | 27 | 0.120 |
Why?
|
| Tetralogy of Fallot | 1 | 2015 | 43 | 0.120 |
Why?
|
| Advisory Committees | 1 | 2015 | 73 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2017 | 313 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2015 | 68 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 940 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 442 | 0.120 |
Why?
|
| Hemorrhage | 1 | 2016 | 328 | 0.120 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 306 | 0.120 |
Why?
|
| Hemodynamics | 2 | 2015 | 705 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2016 | 275 | 0.120 |
Why?
|
| Monitoring, Immunologic | 1 | 2013 | 2 | 0.120 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 71 | 0.120 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2014 | 24 | 0.120 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2014 | 47 | 0.120 |
Why?
|
| Glucose | 1 | 2015 | 307 | 0.110 |
Why?
|
| Acute Disease | 1 | 2015 | 658 | 0.110 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 334 | 0.110 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 792 | 0.110 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2013 | 10 | 0.110 |
Why?
|
| Aortic Coarctation | 1 | 2013 | 37 | 0.110 |
Why?
|
| Knee Injuries | 1 | 2013 | 31 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 249 | 0.110 |
Why?
|
| Recurrence | 3 | 2020 | 948 | 0.110 |
Why?
|
| Knee Joint | 1 | 2013 | 115 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 438 | 0.100 |
Why?
|
| Basal Metabolism | 1 | 2012 | 22 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 109 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2010 | 1553 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2015 | 867 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 333 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 136 | 0.100 |
Why?
|
| Prognosis | 3 | 2015 | 2093 | 0.100 |
Why?
|
| Apgar Score | 1 | 2011 | 22 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 536 | 0.100 |
Why?
|
| Perioperative Period | 1 | 2011 | 24 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2077 | 0.100 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 258 | 0.090 |
Why?
|
| Education, Distance | 1 | 2011 | 34 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 72 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 951 | 0.090 |
Why?
|
| Administration, Inhalation | 2 | 2019 | 187 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2012 | 222 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1745 | 0.090 |
Why?
|
| Brain Ischemia | 1 | 2016 | 665 | 0.090 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 1506 | 0.090 |
Why?
|
| Myocardium | 1 | 2016 | 1204 | 0.090 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 157 | 0.090 |
Why?
|
| Heart Block | 1 | 2009 | 49 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2015 | 1451 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2015 | 596 | 0.080 |
Why?
|
| Patient Readmission | 2 | 2023 | 267 | 0.080 |
Why?
|
| Fatal Outcome | 2 | 2016 | 164 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 2008 | 53 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 2223 | 0.080 |
Why?
|
| Obesity | 1 | 2015 | 1076 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2324 | 0.080 |
Why?
|
| Catheters, Indwelling | 1 | 2008 | 72 | 0.080 |
Why?
|
| North America | 2 | 2018 | 112 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 286 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2009 | 954 | 0.070 |
Why?
|
| Diuresis | 1 | 2006 | 20 | 0.070 |
Why?
|
| Cyclic GMP | 1 | 2005 | 99 | 0.060 |
Why?
|
| Premedication | 1 | 2005 | 49 | 0.060 |
Why?
|
| Equipment Design | 2 | 2017 | 500 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2005 | 99 | 0.060 |
Why?
|
| Elapid Venoms | 1 | 2004 | 5 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2005 | 150 | 0.060 |
Why?
|
| Ultrafiltration | 1 | 2004 | 35 | 0.060 |
Why?
|
| Infant Welfare | 1 | 2004 | 18 | 0.060 |
Why?
|
| Curriculum | 2 | 2021 | 575 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1851 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2004 | 219 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2005 | 222 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 146 | 0.060 |
Why?
|
| Observer Variation | 2 | 2015 | 330 | 0.050 |
Why?
|
| Causality | 1 | 2023 | 82 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 1753 | 0.050 |
Why?
|
| Biomarkers | 2 | 2006 | 1593 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 23 | 0.050 |
Why?
|
| Remission Induction | 1 | 2002 | 111 | 0.050 |
Why?
|
| Consensus | 1 | 2022 | 211 | 0.050 |
Why?
|
| Failure to Thrive | 1 | 2021 | 17 | 0.050 |
Why?
|
| Placenta | 1 | 2022 | 101 | 0.050 |
Why?
|
| Animals | 2 | 2016 | 20881 | 0.050 |
Why?
|
| Delayed Diagnosis | 1 | 2021 | 39 | 0.050 |
Why?
|
| Prevalence | 2 | 2016 | 1619 | 0.050 |
Why?
|
| Peptides | 1 | 2004 | 455 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2002 | 142 | 0.050 |
Why?
|
| Demography | 1 | 2021 | 279 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2003 | 453 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2020 | 21 | 0.050 |
Why?
|
| Enteral Nutrition | 1 | 2022 | 157 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2021 | 56 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2022 | 208 | 0.050 |
Why?
|
| Comorbidity | 2 | 2019 | 1426 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 99 | 0.040 |
Why?
|
| Monitoring, Ambulatory | 1 | 2020 | 84 | 0.040 |
Why?
|
| Reference Values | 1 | 2021 | 579 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 214 | 0.040 |
Why?
|
| Failure to Rescue, Health Care | 1 | 2019 | 7 | 0.040 |
Why?
|
| Oximetry | 1 | 2019 | 29 | 0.040 |
Why?
|
| Reflex, Pupillary | 1 | 2019 | 5 | 0.040 |
Why?
|
| Diagnosis-Related Groups | 1 | 2019 | 28 | 0.040 |
Why?
|
| Information Services | 1 | 2018 | 22 | 0.040 |
Why?
|
| Thinness | 1 | 2019 | 14 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 256 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 502 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 392 | 0.040 |
Why?
|
| Weight Gain | 1 | 2018 | 135 | 0.040 |
Why?
|
| Program Development | 1 | 2018 | 240 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 955 | 0.040 |
Why?
|
| Oxygenators, Membrane | 1 | 2017 | 5 | 0.040 |
Why?
|
| Benchmarking | 1 | 2017 | 91 | 0.040 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2016 | 2 | 0.030 |
Why?
|
| Central Venous Pressure | 1 | 2016 | 11 | 0.030 |
Why?
|
| Vertebral Artery | 1 | 2016 | 22 | 0.030 |
Why?
|
| Quadriplegia | 1 | 2016 | 29 | 0.030 |
Why?
|
| Ligation | 1 | 2016 | 83 | 0.030 |
Why?
|
| Brain Stem | 1 | 2016 | 46 | 0.030 |
Why?
|
| Hepatorenal Syndrome | 1 | 2016 | 16 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 136 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2018 | 294 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2015 | 32 | 0.030 |
Why?
|
| Vasodilation | 1 | 2016 | 85 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2015 | 31 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 48 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 111 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 69 | 0.030 |
Why?
|
| Acidosis, Lactic | 1 | 2015 | 6 | 0.030 |
Why?
|
| Culture Media | 1 | 2015 | 155 | 0.030 |
Why?
|
| Glycolysis | 1 | 2015 | 79 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 93 | 0.030 |
Why?
|
| Caspases | 1 | 2015 | 194 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 85 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 260 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 87 | 0.030 |
Why?
|
| Competency-Based Education | 1 | 2015 | 32 | 0.030 |
Why?
|
| Goals | 1 | 2015 | 65 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 93 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 148 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 114 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 170 | 0.030 |
Why?
|
| Cell Division | 1 | 2015 | 541 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2013 | 35 | 0.030 |
Why?
|
| Oxygen | 1 | 2016 | 386 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 791 | 0.030 |
Why?
|
| Antilymphocyte Serum | 1 | 2013 | 52 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 284 | 0.030 |
Why?
|
| Menisci, Tibial | 1 | 2013 | 6 | 0.030 |
Why?
|
| Teaching | 1 | 2015 | 169 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2015 | 254 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 498 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 307 | 0.030 |
Why?
|
| Patient Safety | 1 | 2015 | 202 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 38 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2015 | 586 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 1200 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 2012 | 12 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 597 | 0.030 |
Why?
|
| Arthroscopy | 1 | 2013 | 95 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 2012 | 43 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2012 | 72 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1140 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 86 | 0.020 |
Why?
|
| Chile | 1 | 2011 | 17 | 0.020 |
Why?
|
| Medical Audit | 1 | 2011 | 44 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 756 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2015 | 617 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 1851 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2013 | 458 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 514 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1641 | 0.020 |
Why?
|
| Internet | 1 | 2011 | 390 | 0.020 |
Why?
|
| Computer Systems | 1 | 2006 | 42 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1535 | 0.020 |
Why?
|
| Calibration | 1 | 2006 | 73 | 0.020 |
Why?
|
| Middle Aged | 2 | 2015 | 21147 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 104 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2006 | 95 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1040 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 234 | 0.010 |
Why?
|
| Algorithms | 1 | 2006 | 1196 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 14862 | 0.010 |
Why?
|